Dr. Jack West reviews the concept of epigenetics, epigenetic priming, and whether oral azacytidine can improve outcomes in patients who receive immunotherapy for advanced lung cancer.
Advertisement
Clinical Trial Spotlight_ Can Epigenetic Priming Improve Efficacy of Immunotherapy in NSCLC_ [360p]
By Editor